Credit Suisse »

Fate Therapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-09-30 $273k 129k 2.12
2023-06-30 $836k 176k 4.76
2023-03-31 $840k 147k 5.70
2022-12-31 $10M 1.0M 10.09
2022-09-30 $23M 1.0M 22.38
2022-06-30 $25M 1.0M 24.80
2022-03-31 $39M 1.0M 38.77
2021-12-31 $58M 999k 58.49
2021-09-30 $60M 1.0M 59.27
2021-06-30 $88M 1.0M 86.79
2021-03-31 $83M 1.0M 82.43
2020-12-31 $69M 760k 90.95
2020-09-30 $30M 745k 39.98
2020-06-30 $28M 802k 34.30
2020-03-31 $16M 693k 23.16
2019-12-31 $17M 849k 19.57
2019-09-30 $13M 846k 15.53
2019-06-30 $17M 727k 23.26
2019-03-31 $1.2M 66k 17.58
2018-12-31 $677k 55k 12.32
2018-09-30 $406k 25k 16.24
2018-06-30 $374k 33k 11.27
2018-03-31 $175k 18k 9.78
2017-12-31 $69k 11k 6.10
2017-09-30 $112k 29k 3.93
2017-03-31 $56k 12k 4.55